The CODEX® Instrument
Empowering Discovery Research
Akoya’s CODEX instrument is a powerful yet simple, bench-top fluidics system that integrates with a companion microscope, Keyence BZ-X 700/800, to automate the CODEX image acquisition.
The CODEX System provides a comprehensive spatial biology solution, converting a standard fluorescent microscope into an automated imaging system to produce ultra-highplex images capable of providing in situ analysis at the cellular and subcellular scales.
Key Features
Simple set up and walk-away operation in a compact design
Automated cyclical reporter-dye delivery and image acquisition
Spatially resolved, ultra-highplex data with morphological context
CODEX chemistry combined with advanced fluidics preserves tissue architecture allowing reuse
Microscope Requirements
CODEX® instrument seamlessly integrates with Keyence BZ-X 700/800 inverted epi-fluorescent microscopes. CODEX-Keyence system is easy-to-use, compact and can be operated without a dark room.
The CODEX® Instrument Manager (CIM) software, part of the CODEX software suite, is co-installed on the Keyence control computer and seamlessly integrates with the Keyence software interface for the synchronization of the CODEX® assay cycles and image acquisition.
CIM provides a user-friendly interface that allows researchers to custom design their experiments and projects, making the setup faster, and easier to execute.
Julia Kennedy-Darling, PhD
Co-Inventor of CODEX Technology and Director of R&D
Akoya Biosciences, Inc
CODEX has really democratized access to spatially resolved, multiplexed immunofluorescence. The integration with existing microscopes enables users to generate high-quality images while keeping the capital investment low.
Julia Kennedy-Darling, PhD
Co-Inventor of CODEX Technology and Director of R&D
Akoya Biosciences, Inc
CODEX has really democratized access to spatially resolved, multiplexed immunofluorescence. The integration with existing microscopes enables users to generate high-quality images while keeping the capital investment low.